GPW
AZN icon

Genesis Private Wealth’s AstraZeneca AZN Stock Holding History

Genesis Private Wealth’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Buy
1,524
+212
+16% +$39.9K 0.08% 136
2026
Q1 		$259K Sell
1,312
-256
-16% -$49.4K 0.08% 146
2025
Q4 		$288K Sell
1,568
-274
-15% -$48.1K 0.09% 128
2025
Q3 		$283K Sell
1,842
-27
-1% -$4.09K 0.12% 104
2025
Q2 		$261K Buy
1,869
+58
+3% +$8.13K 0.12% 111
2025
Q1 		$266K Buy
1,811
+208
+13% +$30.1K 0.14% 99
2024
Q4 		$210K Buy
+1,603
New +$224K 0.12% 123

Other funds holding AZN

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
CAM
Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return
MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return

Genesis Private Wealth's AZN Position: Q2 2026 in Review

Genesis Private Wealth increased its AstraZeneca (AZN) stake by 16% in Q2 2026, buying an estimated $39.9K and bringing the position to 1,524 shares worth $289K. The position accounts for 0.08% of the portfolio, ranked #136.

Genesis Private Wealth first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. 309 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Genesis Private Wealth held 1,524 shares of AstraZeneca worth $289K as of Q2 2026.
  • Genesis Private Wealth bought 212 AstraZeneca shares in Q2 2026, an estimated $39.9K.
  • AstraZeneca made up 0.08% of Genesis Private Wealth's portfolio in Q2 2026, its #136 holding.
  • Genesis Private Wealth first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
  • 309 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Genesis Private Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.